Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |